StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) stock

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)

Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –

Veracyte operating margin

Operating margin is operating income as a percentage of revenue.

Veracyte's operating margin for the twelve months ending Jun 30, 2026 was 18.8%. For fiscal 2025 it was 11.2%, against 3.6% the year before. The highest annual figure on record is 11.2% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202511.2%+7.6
FY2024Dec 31, 20243.6%+27.4
FY2023Dec 31, 2023-23.8%−9.9
FY2022Dec 31, 2022-13.9%+23.5
FY2021Dec 31, 2021-37.3%−7.2
FY2020Dec 31, 2020-30.1%−17.6
FY2019Dec 31, 2019-12.6%+11.6
FY2018Dec 31, 2018-24.2%+12.7
FY2017Dec 31, 2017-36.9%+7.4
FY2016Dec 31, 2016-44.3%+23.3
FY2015Dec 31, 2015-67.6%+8.3
FY2014Dec 31, 2014-76.0%+29.9
FY2013Dec 31, 2013-105.9%+56.9
FY2012Dec 31, 2012-162.8%+414.4
FY2011Dec 31, 2011-577.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202615.3%+19.3
Q1 FY2026Mar 31, 202616.3%+13.7
Q4 FY2025Dec 31, 202526.4%+22.9
Q3 FY2025Sep 30, 202517.4%+7.0
Q2 FY2025Jun 30, 2025-4.0%−8.1
Q1 FY2025Mar 31, 20252.5%+7.3
Q4 FY2024Dec 31, 20243.5%+39.7
Q3 FY2024Sep 30, 202410.4%+45.6
Q2 FY2024Jun 30, 20244.0%+12.9
Q1 FY2024Mar 31, 2024-4.8%+7.9
Q4 FY2023Dec 31, 2023-36.2%−29.4
Q3 FY2023Sep 30, 2023-35.2%−22.4
Q2 FY2023Jun 30, 2023-8.9%+5.8
Q1 FY2023Mar 31, 2023-12.7%+9.8
Q4 FY2022Dec 31, 2022-6.7%+11.6
Q3 FY2022Sep 30, 2022-12.8%+14.8
Q2 FY2022Jun 30, 2022-14.7%−1.2
Q1 FY2022Mar 31, 2022-22.5%+101.2
Q4 FY2021Dec 31, 2021-18.3%+5.1
Q3 FY2021Sep 30, 2021-27.6%−14.6
Q2 FY2021Jun 30, 2021-13.6%+39.8
Q1 FY2021Mar 31, 2021-123.7%−84.5
Q4 FY2020Dec 31, 2020-23.4%+4.2
Q3 FY2020Sep 30, 2020-13.1%−7.4
Q2 FY2020Jun 30, 2020-53.4%−43.1
Q1 FY2020Mar 31, 2020-39.2%−32.2
Q4 FY2019Dec 31, 2019-27.6%−15.7
Q3 FY2019Sep 30, 2019-5.7%+12.6
Q2 FY2019Jun 30, 2019-10.3%+15.7
Q1 FY2019Mar 31, 2019-7.0%+37.7
Q4 FY2018Dec 31, 2018-11.9%+19.0
Q3 FY2018Sep 30, 2018-18.3%+18.0
Q2 FY2018Jun 30, 2018-26.0%+9.9
Q1 FY2018Mar 31, 2018-44.7%+1.1
Q4 FY2017Dec 31, 2017-30.8%−10.7
Q3 FY2017Sep 30, 2017-36.3%−10.1
Q2 FY2017Jun 30, 2017-35.9%–
Q1 FY2017Mar 31, 2017-45.7%–
Q4 FY2016Dec 31, 2016-20.1%–
Q3 FY2016Sep 30, 2016-26.3%–

More Veracyte figures

See a number that looks wrong?